HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koh Furugaki Selected Research

Koh Furugaki Research Topics

Disease

12Neoplasms (Cancer)
01/2020 - 03/2010
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 11/2010
7Lung Neoplasms (Lung Cancer)
01/2022 - 01/2014
2Sarcoma (Soft Tissue Sarcoma)
04/2019 - 02/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
03/2010 - 04/2007
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
02/2014
1Neoplasm Metastasis (Metastasis)
10/2011
1Stomach Neoplasms (Stomach Cancer)
08/2011
1Breast Neoplasms (Breast Cancer)
08/2010
1Hepatocellular Carcinoma (Hepatoma)
01/2009

Drug/Important Bio-Agent (IBA)

8ErbB Receptors (EGF Receptor)IBA
04/2019 - 08/2011
6Tyrosine Kinase InhibitorsIBA
01/2022 - 10/2011
5alectinibIBA
01/2022 - 01/2019
5Anaplastic Lymphoma KinaseIBA
01/2022 - 01/2019
5Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2017 - 03/2010
3Bevacizumab (Avastin)FDA Link
08/2017 - 08/2010
2Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2019
2Pharmaceutical PreparationsIBA
01/2019 - 02/2016
2AntibodiesIBA
08/2011 - 01/2009
1Apoptosis Regulatory ProteinsIBA
01/2020
1Cyclin-Dependent Kinase 4IBA
01/2020
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2020
1Messenger RNA (mRNA)IBA
04/2019
1Biomarkers (Surrogate Marker)IBA
04/2019
1Ado-Trastuzumab EmtansineIBA
01/2019
1src-Family KinasesIBA
01/2019
1CrizotinibIBA
01/2019
1saracatinibIBA
01/2019
1human ERBB2 proteinIBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2017
1B7-H1 AntigenIBA
01/2017
1Codon (Codons)IBA
02/2014
1DNA (Deoxyribonucleic Acid)IBA
02/2014
1Trastuzumab (Herceptin)FDA Link
08/2011
1pertuzumabIBA
08/2011
1Docetaxel (Taxotere)FDA Link
11/2010
1Paclitaxel (Taxol)FDA LinkGeneric
08/2010
1GemcitabineFDA Link
03/2010
1GlypicansIBA
01/2009
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2009
1Complement System Proteins (Complement)IBA
04/2007

Therapy/Procedure

7Therapeutics
01/2022 - 03/2010
1Immunotherapy
01/2017